Kevin Marsh, PhD
Kevin Marsh
Executive Director
Patient-Centered Research, Evidera Ltd, Newport Pagell, UK
Kevin Marsh, PhD, is Vice President at Evidera in London, UK. He specializes in the use of preference data and decision analysis to inform health decisions, including pipeline optimisation, authorisation, reimbursement, and prescription decisions.

Dr Marsh’s research interests include stated and revealed preference methods, decision modelling, and MCDA. He has applied these and other research techniques for a range of organisations, including both regulatory and industry clients. He actively contributes to the methodological development of these techniques. He is currently co-Chairing ISPOR Health Preference SIG and is a member of the ISPOR Task Force on qBRA. He has previously chaired the ISPOR Task Force on the Use of MCDA in Health Care Decision-Making and an ISPOR working group on the use of preference data in Europe.